Strategy planning for turbulent times in nuclear medicine: Time to begin at the beginning?

Eur J Nucl Med Mol Imaging. 2023 Dec;51(1):12-19. doi: 10.1007/s00259-023-06379-x.

Rayjanah Allie¹, Irfan Kayani¹, Gopinath Gnanasegaran^{1

2}, Sobhan Vinjamuri³, Arturo Chiti^{4

5}, Diana Paez⁶, Francesco Giammarile⁶, Ken Herrmann^{7

8}, Jamshed Bomanji⁹

¹ Institute of Nuclear Medicine, University College London Hospital, 5Th Floor, 235 Euston Road, London, NW1 2BU, UK.
² Royal Free London NHS Foundation Trust, London, UK.
³ Royal Liverpool University Hospital, Liverpool, UK.
⁴ Faculty of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy.
⁵ Department of Nuclear Medicine, IRCCS San Raffaele, Milan, Italy.
⁶ Nuclear Medicine and Diagnostic Imaging Section, Department of Nuclear Sciences and Applications at the International Atomic Energy Agency (IAEA), Vienna, Austria.
⁷ Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
⁸ National Center for Tumor Diseases (NCT), NCT West, Heidelberg, Germany.
⁹ Institute of Nuclear Medicine, University College London Hospital, 5Th Floor, 235 Euston Road, London, NW1 2BU, UK. jamshed.bomanji@nhs.net.

No abstract available

Publication types